Guillain-Barré Syndrome After COVID-19 mRNA Vaccination in a Liver Transplantation Recipient With Favorable Treatment Response.

Hughes, Dempsey L; Brunn, Jenna A; Jacobs, Jansen; Todd, Peter K; Askari, Fredrick K; Fontana, Robert J

Hughes, Dempsey L; Brunn, Jenna A; Jacobs, Jansen; Todd, Peter K; Askari, Fredrick K; Fontana, Robert J.

Hughes DL; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI.
Brunn JA; Department of Neurology, University of Michigan, Ann Arbor, MI.
Jacobs J; Department of Internal Medicine, University of Michigan, Ann Arbor, MI.
Todd PK; Department of Neurology, University of Michigan, Ann Arbor, MI.
Askari FK; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI.
Fontana RJ; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI.

Liver Transpl ; 28(1): 134-137, 2022 01.

Article in English | MEDLINE | ID: covidwho-1540149

Subject(s)

COVID-19; Guillain-Barre Syndrome; Liver Transplantation; Guillain-Barre Syndrome/diagnosis; Guillain-Barre Syndrome/etiology; Humans; Liver Transplantation/adverse effects; RNA, Messenger; SARS-CoV-2; Vaccination/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Liver Transplantation / Guillain-Barre Syndrome / COVID-19 Type of study: Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: Liver Transpl Journal subject: Gastroenterology / Transplantation Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google